GPC3 and hepatocellular carcinoma: AFP, GPC3, CRP, and other peripheral blood proteins have been reported as biomarkers for predicting HCC survival or treatment effect, but in our study cohort, we found that baseline circulating SAA level had a higher AUC value for predicting PD status than these peripheral factors, as well as NLR and PLR10,39.